Get my own profile
Public access
View all3 articles
0 articles
available
not available
Based on funding mandates
Co-authors
- Franz von NussbaumBayerVerified email at bayer.com
- Nicolas D. WerbeckProfessor for Molecular Biomedicine, Institute of Precision Medicine, Hochschule FurtwangenVerified email at hs-furtwangen.de
- Ulrich LueckingHead of Chemistry @ FoRx TherapeuticsVerified email at forxtherapeutics.com
- Jörg WeiskeVerified email at kabelmail.de
- Christian M StegmannAbsciVerified email at absci.com
- Erich NiggBiozentrum, University of Basel, SwitzerlandVerified email at unibas.ch
- René PetersProfessor der Organischen Chemie, Universität StuttgartVerified email at oc.uni-stuttgart.de
- Martin EilersProfessor of BiochemistryVerified email at biozentrum.uni-wuerzburg.de
- Giacomo CossaPost doctoral fellow, University of WürzburgVerified email at uni-wuerzburg.de
- Ralf LescheSenior Principal Scientist, Nuvisan ICB GmbHVerified email at nuvisan.com
- David R SpringUniversity of CambridgeVerified email at ch.cam.ac.uk
- Simon HerbertBayer AGVerified email at bayer.com
- Clara ChristVerified email at alumni.ethz.ch
- Christofer TautermannDirector Computational Chemistry, Boehringer Ingelheim Pharma GmbH & Co KGVerified email at boehringer-ingelheim.com
- Tom BretschneiderBoehringer IngelheimVerified email at boehringer-ingelheim.com
Follow
Lars Wortmann
Medicinal Chemist, Boehringer Ingelheim (before Schering AG & Bayer AG)
Verified email at boehringer-ingelheim.com - Homepage